| Foreword |
|
vii | |
| Preface |
|
ix | |
|
Part I Secondary Hereditary and Acquired Cardiac Channelopathies and Sudden Cardiac Death |
|
|
|
|
|
|
|
|
|
|
|
1 Introduction to Part Three Cardiac Remodeling |
|
|
3 | (4) |
|
|
|
2 Arrhythmias and Arrhythmia Management in Hypertrophic Cardiomyopathy |
|
|
7 | (18) |
|
|
|
|
|
|
|
3 Sudden Cardiac Death in Dilated Cardiomyopathy and Skeletal Muscular Dystrophy |
|
|
25 | (16) |
|
Ingrid A.W. van Rijsingen |
|
|
|
|
|
|
4 Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia |
|
|
41 | (14) |
|
|
|
|
|
5 The Wolff-Parkinson-White Syndrome and the Risk of Sudden Death |
|
|
55 | (18) |
|
|
|
|
|
|
|
|
|
|
|
6 Acquired (Drug-Induced) Long and Short QT Syndromes |
|
|
73 | (50) |
|
|
|
|
|
7 Acquired Form of Brugada Syndrome |
|
|
123 | (18) |
|
|
|
Part II Clinical Rhythmology: Diagnostic Methods and Tools |
|
|
|
|
|
|
|
|
|
|
|
|
|
8 Introduction to Part IV: Abnormal Electrical Functions of the Heart and Their Diagnoses in Clinic |
|
|
141 | (4) |
|
|
|
9 Diagnostic Electrocardiography |
|
|
145 | (14) |
|
|
|
10 Microvolt T Wave Alternans: Mechanisms and Implications for Prediction of Sudden Cardiac Death |
|
|
159 | (20) |
|
|
|
|
|
|
|
|
|
11 Heart Rate Variability: Measurements and Risk Stratification |
|
|
179 | (18) |
|
|
|
12 Orthostatic Challenge Tests: Active Standing and Head-Up Tilt |
|
|
197 | (12) |
|
Louise R.A. Olde Nordkamp |
|
|
|
|
|
|
|
|
209 | (14) |
|
|
|
|
|
|
|
|
|
14 Surface Mapping and Magneto-Electrocardiography |
|
|
223 | (16) |
|
|
|
|
|
15 Ambulatory Monitoring: (Holter, Event Recorders, External, and Implantable Loop Recorders and Wireless Technology) |
|
|
239 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 Device Therapy for Remote Patient Management |
|
|
255 | (16) |
|
|
|
|
|
|
|
17 Invasive Electrophysiologic Testing: Role in Sudden Death Prediction |
|
|
271 | (18) |
|
|
|
|
|
18 Provocative (Drug) Testing in Inherited Arrhythmias |
|
|
289 | (12) |
|
|
|
|
|
19 Novel Predictors of Sudden Cardiac Death |
|
|
301 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
315 | (20) |
|
|
|
|
|
Part III Risk Stratification of Sudden Cardiac Death in Acquired Clinical Conditions |
|
|
|
|
|
|
|
|
|
|
|
|
|
21 Introduction to Part Five: Screening for Risk of Sudden Cardiac Death |
|
|
335 | (4) |
|
|
|
22 Risk Stratification for Sudden Death in Patients with Coronary Artery Disease |
|
|
339 | (24) |
|
|
|
|
|
|
|
23 Sudden Death in Athletes |
|
|
363 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 Cardiac Channelopathies and Sudden Infant Death Syndrome |
|
|
381 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
25 Heart Failure and Sudden Death |
|
|
395 | (18) |
|
|
|
|
|
26 Neurologic Conditions and Sudden Death |
|
|
413 | (12) |
|
|
|
|
|
27 Sudden Cardiac Death and Alcohol |
|
|
425 | (16) |
|
|
|
|
|
28 Sudden Cardiac Death and Addictive Chemical Substances |
|
|
441 | (20) |
|
|
|
|
|
29 Obstructive Sleep Apnea and Sudden Death |
|
|
461 | (14) |
|
|
|
|
|
30 Sudden Cardiac Arrest in Chronic Kidney Disease |
|
|
475 | (12) |
|
|
|
|
|
|
|
|
|
31 Clinical Trials in Sudden Cardiac Death Prevention: Principles and Endpoints |
|
|
487 | (10) |
|
|
|
Part IV Treatment and Prevention Modalities |
|
|
|
|
|
|
|
|
|
|
|
32 Introduction to Part IV: Treatment Modalities |
|
|
497 | (4) |
|
|
|
33 Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death |
|
|
501 | (24) |
|
|
|
|
|
34 Non-antiarrhythmic Drugs in Sudden Death Prevention |
|
|
525 | (18) |
|
|
|
|
|
|
|
35 Non-surgical Treatment and Prevention of Atrial Fibrillation |
|
|
543 | (18) |
|
|
|
|
|
36 Surgical Treatment of Atrial Fibrillation |
|
|
561 | (16) |
|
|
|
|
|
37 Catheter Ablation for Triggered Ventricular Fibrillation and Polymorphic Ventricular Tachycardia |
|
|
577 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
38 Catheter Ablation for Scar-Dependent Ventricular Tachycardia |
|
|
591 | (20) |
|
|
|
|
|
39 The Implantable Cardioverter Defibrillator: Technical and Clinical Considerations |
|
|
611 | (10) |
|
|
|
|
|
40 Beyond Sudden Death Prevention: Minimizing ICD Shocks and Morbidity, and Optimizing Efficacy |
|
|
621 | (28) |
|
|
|
|
|
|
|
|
|
|
|
41 Pacing and Cardiac Resynchronization |
|
|
649 | (10) |
|
|
| Index |
|
659 | |
Lisainfo e-raamatute kohta